{"product_id":"quantitative-drug-safety-and-benefit-risk-evaluation-practical-and-cross-disciplinary-approaches-9781032191119","title":"Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches","description":"\u003cp\u003eThis book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e William Wang\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e CRC Press\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 01\/29\/2024\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 382\u003cbr\u003e\u003cb\u003eBinding Type:\u003c\/b\u003e Paperback\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.24lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 9.21h x 6.14w x 0.83d\u003cbr\u003e\u003cb\u003eISBN:\u003c\/b\u003e 9781032191119\u003cbr\u003e\u003cp\u003e\u003cb\u003eAbout the Author\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003eDr. William (Bill) Wang\u003c\/b\u003e is currently Executive Director in the department of Biostatistics and Research Decision Sciences, Merck Research Laboratories, where he has worked for 20+ years. Bill has served as the deputy topics-leader for the ICH E17 Working Group and has co-chaired the ASA Biopharmaceutical Safety Working Group. He is an elected ASA Fellow.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eDr. Melvin S. Munsaka\u003c\/b\u003e is currently Senior Director and Head of Safety Statistics at AbbVie. He has more than 25 years of industry experience. He is a member of the ASA Biopharmaceutical Safety Scientific Working Group, DIA Bayesian Scientific Working Group, and the PHUSE Safety Analytics Working Group\u003c\/p\u003e\u003cp\u003e\u003cb\u003eDr. James Buchanan, \u003c\/b\u003e president of Covilance LLC, has 30+ years of drug safety experience in the pharmaceutical industry. He is a co-lead of the ASA Biopharmaceutical Safety Working Group and the Interactive Safety Graphics taskforce that is developing novel, open-source, interactive graphical tools to evaluate drug safety issues.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eDr. Judy X. Li\u003c\/b\u003e is currently Senior Director, Biostatistics Lead for San Diego site Bristol Myers Squibb. She also has extensive experience working at the US Food and Drug Administration as a master statistical reviewer and supervisory mathematical statistician. She is the founding co-chair of the ASA Biopharmaceutical Safety Working Group.\u003c\/p\u003e\u003cbr\u003e\u003cp\u003e\u003ci\u003eThis title is not returnable\u003c\/i\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"CRC Press","offers":[{"title":"Paperback","offer_id":43255714807923,"sku":"9.78103E+12","price":117.15,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0555\/9255\/0515\/files\/img_9bc36ecf-6180-4ad4-a4aa-7ce06d8c08cb.jpg?v=1754566508","url":"https:\/\/bookstorenmore.com\/products\/quantitative-drug-safety-and-benefit-risk-evaluation-practical-and-cross-disciplinary-approaches-9781032191119","provider":"Bookstore N More","version":"1.0","type":"link"}